Advertisement
Screener

NewcelX Ltd. (NCEL) Form 6-K: Report of foreign private issuer, 2022

1.9 / 5 stars · 8/21 Roast Me

Add as a preferred source on Google

NewcelX Ltd. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2022-12-22: Form 6-K; Period of report 2022-12-22; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea170647-6k_nlspharma.htm.
  • 2022-12-20: Form 6-K; Period of report 2022-12-20; Description REPORT OF FOREIGN PRIVATE ISSUER; Document ea170572-6k_nlspharma.htm.
  • 2022-12-16: Form 6-K/A; Period of report 2022-12-16; Description AMENDMENT NO. 1 TO FORM 6-K; Document ea170354-6ka1_nlspharma.htm.
  • 2022-12-14: Form 6-K; Period of report 2022-12-14; Description CURRENT REPORT; Document ea170169-6k_nls.htm.
FiledFormPeriod of reportDescriptionDocument
2022-12-226-K2022-12-22REPORT OF FOREIGN PRIVATE ISSUERea170647-6k_nlspharma.htm
2022-12-206-K2022-12-20REPORT OF FOREIGN PRIVATE ISSUERea170572-6k_nlspharma.htm
2022-12-166-K/A2022-12-16AMENDMENT NO. 1 TO FORM 6-Kea170354-6ka1_nlspharma.htm
2022-12-146-K2022-12-14CURRENT REPORTea170169-6k_nls.htm
2022-12-146-K2022-12-13REPORT OF FOREIGN PRIVATE ISSUERea170132-6k_nlspharma.htm
2022-12-086-K2022-12-08REPORT OF FOREIGN PRIVATE ISSUERea169823-6k_nlspharmaceutics.htm
2022-12-076-K2022-12-07REPORT OF FOREIGN PRIVATE ISSUERea169759-6k_nlspharmaceutics.htm
2022-12-016-K2022-12-01REPORT OF FOREIGN PRIVATE ISSUERea169499-6k_nlspharma.htm
2022-11-236-K2022-11-23REPORT OF FOREIGN PRIVATE ISSUERea169166-6k_nlspharma.htm
2022-11-146-K2022-11-14REPORT OF FOREIGN PRIVATE ISSUERea168548-6k_nlspharma.htm
2022-11-076-K2022-11-07REPORT OF FOREIGN PRIVATE ISSUERea168121-6k_nlspharmaceutics.htm
2022-11-026-K2022-11-02REPORT OF FOREIGN PRIVATE ISSUERea167916-6k_nlspharma.htm
2022-10-286-K2022-10-28REPORT OF FOREIGN PRIVATE ISSUERea167731-6k_nlspharma.htm
2022-10-116-K2022-06-30REPORT OF FOREIGN PRIVATE ISSUERea166878-6k_nlspharma.htm
2022-10-076-K2022-10-07REPORT OF FOREIGN PRIVATE ISSUERea166893-6k_nlspharma.htm
2022-10-066-K2022-10-06REPORT OF FOREIGN PRIVATE ISSUERea166819-6k_nlspharma.htm
2022-10-036-K2022-10-03REPORT OF FOREIGN PRIVATE ISSUERea166644-6k_nlspharma.htm
2022-09-276-K2022-09-27REPORT OF FOREIGN PRIVATE ISSUERea166364-6k_nlspharma.htm
2022-09-166-K2022-09-16REPORT OF FOREIGN PRIVATE ISSUERea165888-6k_nlspharma.htm
2022-09-166-K/A2022-09-16AMENDMENT NO. 1 TO FORM 6-Kea165719-6ka1_nlspharma.htm
2022-09-086-K2022-09-08REPORT OF FOREIGN PRIVATE ISSUERea165474-6k_nlspharma.htm
2022-08-236-K2022-08-23REPORT OF FOREIGN PRIVATE ISSUERea164849-6k_nlspharma.htm
2022-07-286-K2022-07-28REPORT OF FOREIGN PRIVATE ISSUERea163468-6k_nlspharma.htm
2022-07-216-K2022-07-21Report of foreign private issuerea163112-6k_nlspharma.htm
2022-06-106-K2022-06-10REPORT OF FOREIGN PRIVATE ISSUERea161406-6k_nls.htm
2022-06-066-K2022-06-06REPORT OF FOREIGN PRIVATE ISSUERea161163-6k_nlspharma.htm
2022-06-036-K2022-06-03REPORT OF FOREIGN PRIVATE ISSUERea161145_6k-nlspharma.htm
2022-06-026-K2022-06-02REPORT OF FOREIGN PRIVATE ISSUERea161027-6k_nlspharma.htm
2022-06-016-K2022-06-01REPORT OF FOREIGN PRIVATE ISSUERea161009-6k_nlspharma.htm
2022-05-116-K2022-05-11REPORT OF FOREIGN PRIVATE ISSUERea159747-6k_nlspharmac.htm
2022-05-046-K2022-05-046-Kea159354-6k_nlspharmac.htm
2022-04-276-K2022-04-27REPORT OF FOREIGN PRIVATE ISSUERea158916-6k_nlspharm.htm
2022-04-256-K2022-04-25REPORT OF FOREIGN PRIVATE ISSUERea158811-6k_nlspharma.htm
2022-04-146-K2022-04-14REPORT OF FOREIGN PRIVATE ISSUERea158402-6k_nlspharma.htm
2022-04-066-K2022-04-06REPORT OF FOREIGN PRIVATE ISSUERea158151-6k_nlspharma.htm
2022-04-016-K2022-04-01REPORT OF FOREIGN PRIVATE ISSUERea157809-6k_nlspharm.htm
2022-03-316-K2022-03-31REPORT OF FOREIGN PRIVATE ISSUERea157660-6k_nlspharma.htm
2022-03-286-K2022-03-28REPORT OF FOREIGN PRIVATE ISSUERea157449-6k_nlspharma.htm
2022-03-166-K2022-03-16REPORT OF FOREIGN PRIVATE ISSUERea156904-6k_nlspharma.htm
2022-03-046-K2022-03-04REPORT OF FOREIGN PRIVATE ISSUERea156463-6k_nlspharma.htm
2022-02-076-K2022-02-07REPORT OF FOREIGN PRIVATE ISSUERea155020-6k_nlspharma.htm
2022-01-046-K2022-01-04REPORT OF FOREIGN PRIVATE ISSUERea153384-6k_nlspharma.htm
Advertisement